Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document

Untitled source document

No live link available for this source.

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Stage 1 of the Minim Martap development remains fully funded through the ~US$95 million undrawn portion of the Company's US$140 million credit facility with AFG Bank Cameroon along with the Company's current unaudited cash position of ~US$43 million as at 28 February 2026

    60% confidence
  • The mobilisation of the surface miner represents an important step as Minim Martap moves rapidly towards production and with mining set to commence shortly and financing confirmed through to first shipment, the Company remains on track to deliver its first bauxite shipment in Q3, 2026

    60% confidence
  • The 20-year mining schedule represents only 13.1% of the current Minim Martap Resource and technical studies have identified opportunities for a significant future increase in the production target

    60% confidence
  • We continue to advance logistics, offtake discussions and our downstream feasibility study to maximise the long-term value of this tier-one, globally significant, high-grade bauxite project

    60% confidence
  • Updated financial cashflow modelling confirms that the Company's current cash position along with AFG debt financing fully supports the Company's CAPEX requirements for Stage 1 as outlined in the DFS, enabling first ore shipment in Q3, 2026, without the need for additional funding from EEA or Afriland

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com